Generics 5

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Lisdexamfetamine manufacturers

5 products found

Filters

Filters

Filters , active

Country of origin : Greece

Clear all

5 products found

lisdexamfetamine

Oral solution 10 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #35065

Established in 2016, this manufacturer specializes in the development, out-licensing, and supply of high-quality generic pharmaceutical products and value-added medicines. As a CTD dossier owner and manufacturer, it ensures compliance with international quality standards. The manufacturer offers a robust supply chain and a comprehensive range of services covering all stages of the pharmaceutical value chain, from product development to regulatory approval and life cycle management. Its product portfolio includes value-added solid dosage forms (tablets and capsules), injectables, oral solutions, and suspensions, with generics suitable for Day 1 launch upon patent expiry. As a CTD dossier owner and manufacturer, its products are distributed across multiple countries worldwide.

Manufacturer usually replies in 2 days

lisdexamfetamine

Capsules 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #35065

Established in 2016, this manufacturer specializes in the development, out-licensing, and supply of high-quality generic pharmaceutical products and value-added medicines. As a CTD dossier owner and manufacturer, it ensures compliance with international quality standards. The manufacturer offers a robust supply chain and a comprehensive range of services covering all stages of the pharmaceutical value chain, from product development to regulatory approval and life cycle management. Its product portfolio includes value-added solid dosage forms (tablets and capsules), injectables, oral solutions, and suspensions, with generics suitable for Day 1 launch upon patent expiry. As a CTD dossier owner and manufacturer, its products are distributed across multiple countries worldwide.

Manufacturer usually replies in 2 days

lisdexamfetamine

Oral suspension 10 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Uruguay
Manufacturer #8593
It is a private R&D and business development organization established in the 2000s, specializing in the design and development of new pharmaceutical products worldwide. They have an average of 5-6 new developments per year, an average of 8-10 DCPs per year, more than 60 dossier updates in the last 10 years, they have more than 3 valid and approved patent applications, and approximately 140 MAs worldwide.

Manufacturer usually replies in 4 days

Want to see all 5 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible